Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has entered into agreements for the refinancing of the convertible notes currently on issue through an assignment and variation arrangement.
The Directors present their report together with the financial statements, on the consolidated entity (referred to hereafter as 'the Group'), consisting of Cann Global Limited ('the Company') and the entities it controlled at the end of or during the half-year ended 31 December 2019.
Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has agreed to place 34 million new fully paid ordinary shares (New Shares) to institutional and sophisticated investors led by New York-based Sea Otter Global.
Cann Global Limited (ASX:CGB) was pleased to announce a distribution agreement with Costco Australia for our premium quality certified organic hemp seed oil capsules in September.
The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam and its supply of T12 products to COSTCO Australia.
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it has entered into a Heads of Agreement with the South African company Koegas Medicinal Herbs (Pty) Ltd to establish a Joint Venture (CGB to hold 70%) in medicinal Cannabis production and distribution in Africa.
Board of Cann Global Limited (ASX:CGB) is delighted to announce an agreement to secure the exclusive rights to the IP of the unique medicinal cannabis formulations that have been used by Olivia Newton John in her recent health challenge.
Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's operations of business for three of its divisions and its mining interest.
Cann Global Limited (ASX:CGB) has been achieving significant milestones in these past 12 months. The most notable being the undertaking and successful completion of a very extensive and technically comprehensive re-compliance process
Anatara Lifsciences Ltd (ASX:ANR) CEO Steve Lydeamore To Present at the Pitt Street Research Life Sciences Conference
Anatara's CEO Steve Lydeamore has been invited to present at the Pitt Street Research Life Sciences Conference on the 28th November in Sydney. Any investors interested in attending these presentations are invited to reach out.
Banking & Finance
- NSX Ltd (ASX:NSX) AFR Apology to John Karantzis, Managing Director
- VCEX Exchange (VCEX:VEX) Interview With David Pillinger on Raising Capital for Australian Companies
- iSignthis Ltd (ASX:ISX) Annual Report to Shareholders
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) March Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Range Pilot Update - Range-7 Spuds and Range-6 Completed
- Central Petroleum Limited (ASX:CTP) Mereenie Recompletions Commence